Dolutegravir in Real Life in Lesotho

CompletedOBSERVATIONAL
Enrollment

1,433

Participants

Timeline

Start Date

February 10, 2020

Primary Completion Date

May 19, 2021

Study Completion Date

May 20, 2021

Conditions
HIV-1-infection
Interventions
DRUG

Dolutegravir

Eligibility to receive DTG-based ART at enrolment (i.e., initiation or offer to initiate DTG-based ART)

Trial Locations (2)

Unknown

Butha-Buthe Government Hospital, Butha-Buthe

Seboche Mission Hospital, Butha-Buthe

All Listed Sponsors
collaborator

SolidarMed

OTHER

collaborator

Ministry of Health, Lesotho

OTHER_GOV

collaborator

District Health Management Team of Butha-Buthe, Lesotho

OTHER

collaborator

District Health Management Team of Mokhotlong, Lesotho

OTHER

collaborator

University of Basel

OTHER

lead

Swiss Tropical & Public Health Institute

OTHER

NCT04238767 - Dolutegravir in Real Life in Lesotho | Biotech Hunter | Biotech Hunter